Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia

2017

Cell Stem Cell

Windrem MS, Osipovitch M, Liu Z, Bates J, Chandler-Militello D, Zou L, Munir J, Schanz S, McCoy K, Miller RH, Wang S, Nedergaard M, Findling RL, Tesar PJ, Goldman SA.

Transcription elongation factors represent in vivo cancer dependencies in glioblastoma

2017

Nature

Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, Factor DC, Kim LJY, Morrow JJ, Wu Q, Mack SC, Hubert CG, Gillespie SM, Flavahan WA, Hoffmann T, Thummalapalli R, Hemann MT, Paddison PJ, Horbinski CM, Zuber J, Scacheri PC, Bernstein BE, Tesar PJ, Rich JN.

Modeling the mutational and phenotypic landscapes of Pelizaeus-Merzbacher disease with human iPSC-derived oligodendrocytes

2017

American Journal of Human Genetics

Nevin ZS, Factor DC, Karl RT, Douvaras P, Laukka J, Windrem MS, Goldman SA, Fossati V, Hobson GM, Tesar PJ.

Transcriptome-wide analyses of human neonatal articular cartilage and human mesenchymal stem cell-derived cartilage provide a new molecular target for evaluating engineered cartilage.

2017

Tissue Engineering Part A

Somoza RA, Correa D, Labat I, Sternberg H, Forrest ME, Khalil AM, West MD, Tesar P, Caplan AI.

iPSC reprogramming is not just an open and shut case

2017

Cell Stem Cell

Tesar PJ, Scacheri PC.

Clemastine fumarate for promotion of optic nerve remyelination

2017

Lancet

Cohen JA, Tesar PJ.

Cell-based therapeutic strategies for multiple sclerosis

2017

Brain

Scolding NJ, Pasquini M, Reingold SC, Cohen JA; International Conference on Cell-Based Therapies for Multiple Sclerosis.

Reprogramming of mouse fibroblasts to induced oligodendrocyte progenitor cells

2017

Stem Cell Technologies in Neuroscience
Neuromethods, Springer

Karl R, Lager A, Najm F, Tesar PJ.

Stem cell-based treatment of Pelizaeus-Merzbacher disease

2017

Stem Cells

Osorio MJ, Rowitch DH, Tesar PJ, Wernig M, Windrem MS, Goldman SA.